In addition to hematological cancers [6], some solid tumors, such as breast cancer, melanoma, and pancreatic ductal adenocarcinoma, were also reported to be reliant on MCL1 for survival [34]. Here, MCL1 is linked to hematopoietic and lymphoid cell neoplasm.